Products for Research Use Only
RegisterLogin

Cyy-272

CAT: 0804-HY-169052Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-169052Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cyy-272 is an orally active JNK inhibitor with IC50 values of 1.25 μM for JNK1, 1.07 μM for JNK2, and 1.24 μM for JNK3. Cyy-272 exerts anti-inflammatory effects by inhibiting JNK phosphorylation, thereby alleviating acute lung injury (ALI) induced by lipopolysaccharide (LPS, HY-D1056). Additionally, Cyy-272 significantly reduces inflammation in cardiomyocytes and cardiac tissue induced by high lipid concentrations, further mitigating cardiac hypertrophy, fibrosis, and apoptosis. Cyy-272 can be used in the study of obese cardiomyopathy[1].
CAS Number
2644673-01-6
UNSPSC
12352005
Target
Apoptosis; JNK
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cyy-272.html
Smiles
CC1=C(N=C(N=C1)NC2=CC=C(C=C2)N3CCC(F)(CC3)F)NC4=CC=C5C=NNC5=C4
Molecular Formula
C23H23F2N7
Molecular Weight
435.47
References & Citations
[1]Liu X, et al. Cyy-272, an indazole derivative, effectively mitigates obese cardiomyopathy as a JNK inhibitor. Biomed Pharmacother. 2024 Sep;178:117172.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JNK1; JNK2; JNK3

Related Products

CatalogName
HY-106920Kynostatin 272
HY-101925-01CM-272
HY-100726-01GNE-272
HY-163901-01E6-272
HY-100726RGNE-272 (Standard)
HY-W952895CRBN ligand-272
HY-173473Anticancer agent 272
HY-173192Antibacterial agent 272
HY-155489-01DDO-2728
HY-P991515TQH-2722

Alternative Products

CatalogName
GTR17963001Cyy-1 Antibody
BA4690-10GNE-272
A8745-25CM-272
NUA79385-01ARN 272
B2570-5ARN-272
T29812-01AL-272
T89394-01E6-272
T27737-01KNI-272

Popular Products